ANTHONY P. ADAMIS - 23 Jun 2022 Form 3 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
Ron Honig, Attorney-in-Fact for Adamis Anthony P
Issuer symbol
EYPT
Transactions as of
23 Jun 2022
Net transactions value
$0
Form type
3
Filing time
27 Jun 2022, 16:37:18 UTC
Next filing
22 Jun 2023

No securities are beneficially owned.